Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001181431-04-016507
Filing Date
2004-03-18
Accepted
2004-03-18 20:21:49
Documents
1
Period of Report
2004-03-18

Document Format Files

Seq Description Document Type Size
1 FORM 4/A rrd37153.html 4/A  
1 FORM 4/A rrd37153.xml 4/A 5880
  Complete submission text file 0001181431-04-016507.txt   7796
Mailing Address 125 SUMMER STREET BOSTON MA 02110
Business Address 125 SUMMER STREET BOSTON MA 02110 6179332130
POINT THERAPEUTICS INC (Issuer) CIK: 0000919745 (see all company filings)

EIN.: 043216862 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address CLAFLIN CAPITAL MANAGEMENT INC 10 LIBERTY SQ STE 300 BOSTON MA 02110 6174266505
CLAFLIN THOMAS M II (Reporting) CIK: 0001187889 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-23776 | Film No.: 04678708